US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist

0.790
-0.020-2.47%

Close Aug 9 16:00 ET

0.830
+0.040+5.00%

Post 20:02 ET

27.43MMarket Cap-1338P/E (TTM)

MiNK Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-34.58%3.83M

-25.94%22.92M

-30.28%5.5M

-34.60%5.22M

-17.60%6.34M

-20.61%5.85M

9.14%30.95M

-50.89%7.89M

92.51%7.99M

72.90%7.7M

Selling and administrative expenses

-22.89%1.28M

-5.14%7.43M

5.40%2.19M

-2.25%1.8M

-2.05%1.78M

-20.81%1.66M

68.84%7.83M

-12.06%2.08M

125.50%1.84M

109.97%1.82M

-General and administrative expense

-22.89%1.28M

-5.14%7.43M

5.40%2.19M

-2.25%1.8M

-2.05%1.78M

-20.81%1.66M

68.84%7.83M

-12.06%2.08M

125.50%1.84M

109.97%1.82M

Research and development costs

-39.20%2.55M

-32.99%15.49M

-43.04%3.31M

-44.27%3.43M

-22.42%4.56M

-20.54%4.19M

65.51%23.12M

47.14%5.81M

84.45%6.15M

63.93%5.88M

Operating profit

34.58%-3.83M

25.94%-22.92M

30.28%-5.5M

34.60%-5.22M

17.60%-6.34M

20.61%-5.85M

-9.14%-30.95M

50.89%-7.89M

-92.51%-7.99M

-72.90%-7.7M

Net non-operating interest income expense

-90.11%16.62K

82.87%463.26K

-69.20%41.53K

15.41%107.29K

454.99%146.39K

19,917.81%168.06K

110.42%253.32K

8,815.90%134.84K

110.55%92.96K

103.28%26.38K

Non-operating interest income

-90.11%16.62K

82.87%463.26K

-69.20%41.53K

15.41%107.29K

----

--168.06K

--253.32K

--134.84K

--92.96K

----

Total other finance cost

----

-454.99%-146.39K

----

-103.28%-26.38K

Other net income (expense)

-100.00%-10

99.88%-18

-100.00%8

368.41%2.7M

-100.15%-15.37K

116.92%1.56M

244.70%1.56M

Other non- operating income (expenses)

----

-100.00%-10

99.88%-18

-100.00%8

----

1,118.79%2.7M

-100.15%-15.37K

116.29%1.56M

244.70%1.56M

Income before tax

32.94%-3.81M

19.77%-22.46M

29.75%-5.46M

19.20%-5.12M

-1.38%-6.2M

26.89%-5.69M

7.35%-27.99M

-34.79%-7.77M

55.62%-6.33M

3.51%-6.11M

Income tax

Net income

32.94%-3.81M

19.77%-22.46M

29.75%-5.46M

19.20%-5.12M

-1.38%-6.2M

26.89%-5.69M

7.35%-27.99M

-34.79%-7.77M

55.62%-6.33M

3.51%-6.11M

Net income continuous Operations

32.94%-3.81M

19.77%-22.46M

29.75%-5.46M

19.20%-5.12M

-1.38%-6.2M

26.89%-5.69M

7.35%-27.99M

-34.79%-7.77M

55.62%-6.33M

3.51%-6.11M

Minority interest income

Net income attributable to the parent company

32.94%-3.81M

19.77%-22.46M

29.75%-5.46M

19.20%-5.12M

-1.38%-6.2M

26.89%-5.69M

7.35%-27.99M

-34.79%-7.77M

55.62%-6.33M

3.51%-6.11M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

32.94%-3.81M

19.77%-22.46M

29.75%-5.46M

19.20%-5.12M

-1.38%-6.2M

26.89%-5.69M

7.35%-27.99M

-34.79%-7.77M

55.62%-6.33M

3.51%-6.11M

Basic earnings per share

35.29%-0.11

21.69%-0.65

34.78%-0.15

21.05%-0.15

0.00%-0.18

26.09%-0.17

28.45%-0.83

-33.57%-0.23

56.23%-0.19

19.32%-0.18

Diluted earnings per share

35.29%-0.11

21.69%-0.65

34.78%-0.15

21.05%-0.15

0.00%-0.18

26.09%-0.17

28.45%-0.83

-33.57%-0.23

56.23%-0.19

19.32%-0.18

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-34.58%3.83M	-25.94%22.92M	-30.28%5.5M	-34.60%5.22M	-17.60%6.34M	-20.61%5.85M	9.14%30.95M	-50.89%7.89M	92.51%7.99M	72.90%7.7M
Selling and administrative expenses	-22.89%1.28M	-5.14%7.43M	5.40%2.19M	-2.25%1.8M	-2.05%1.78M	-20.81%1.66M	68.84%7.83M	-12.06%2.08M	125.50%1.84M	109.97%1.82M
-General and administrative expense	-22.89%1.28M	-5.14%7.43M	5.40%2.19M	-2.25%1.8M	-2.05%1.78M	-20.81%1.66M	68.84%7.83M	-12.06%2.08M	125.50%1.84M	109.97%1.82M
Research and development costs	-39.20%2.55M	-32.99%15.49M	-43.04%3.31M	-44.27%3.43M	-22.42%4.56M	-20.54%4.19M	65.51%23.12M	47.14%5.81M	84.45%6.15M	63.93%5.88M
Operating profit	34.58%-3.83M	25.94%-22.92M	30.28%-5.5M	34.60%-5.22M	17.60%-6.34M	20.61%-5.85M	-9.14%-30.95M	50.89%-7.89M	-92.51%-7.99M	-72.90%-7.7M
Net non-operating interest income expense	-90.11%16.62K	82.87%463.26K	-69.20%41.53K	15.41%107.29K	454.99%146.39K	19,917.81%168.06K	110.42%253.32K	8,815.90%134.84K	110.55%92.96K	103.28%26.38K
Non-operating interest income	-90.11%16.62K	82.87%463.26K	-69.20%41.53K	15.41%107.29K	----	--168.06K	--253.32K	--134.84K	--92.96K	----
Total other finance cost	----	----	----	----	-454.99%-146.39K	----	----	----	----	-103.28%-26.38K
Other net income (expense)		-100.00%-10	99.88%-18	-100.00%8			368.41%2.7M	-100.15%-15.37K	116.92%1.56M	244.70%1.56M
Other non- operating income (expenses)	----	-100.00%-10	99.88%-18	-100.00%8	----	----	1,118.79%2.7M	-100.15%-15.37K	116.29%1.56M	244.70%1.56M
Income before tax	32.94%-3.81M	19.77%-22.46M	29.75%-5.46M	19.20%-5.12M	-1.38%-6.2M	26.89%-5.69M	7.35%-27.99M	-34.79%-7.77M	55.62%-6.33M	3.51%-6.11M
Income tax
Net income	32.94%-3.81M	19.77%-22.46M	29.75%-5.46M	19.20%-5.12M	-1.38%-6.2M	26.89%-5.69M	7.35%-27.99M	-34.79%-7.77M	55.62%-6.33M	3.51%-6.11M
Net income continuous Operations	32.94%-3.81M	19.77%-22.46M	29.75%-5.46M	19.20%-5.12M	-1.38%-6.2M	26.89%-5.69M	7.35%-27.99M	-34.79%-7.77M	55.62%-6.33M	3.51%-6.11M
Minority interest income
Net income attributable to the parent company	32.94%-3.81M	19.77%-22.46M	29.75%-5.46M	19.20%-5.12M	-1.38%-6.2M	26.89%-5.69M	7.35%-27.99M	-34.79%-7.77M	55.62%-6.33M	3.51%-6.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	32.94%-3.81M	19.77%-22.46M	29.75%-5.46M	19.20%-5.12M	-1.38%-6.2M	26.89%-5.69M	7.35%-27.99M	-34.79%-7.77M	55.62%-6.33M	3.51%-6.11M
Basic earnings per share	35.29%-0.11	21.69%-0.65	34.78%-0.15	21.05%-0.15	0.00%-0.18	26.09%-0.17	28.45%-0.83	-33.57%-0.23	56.23%-0.19	19.32%-0.18
Diluted earnings per share	35.29%-0.11	21.69%-0.65	34.78%-0.15	21.05%-0.15	0.00%-0.18	26.09%-0.17	28.45%-0.83	-33.57%-0.23	56.23%-0.19	19.32%-0.18
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall